# PORTFOLIO_COURT_2026-09-03_0740_WEEKLY

## Inputs Consulted
- [[01_MASTER_LEDGER/CAOS Master Ledger — CANONICAL]] — STATUS: INITIALIZED (2026-08-31, refreshed 2026-09-02); 8 funded holdings, €0.95 real cash, draft §11 portfolio-count/sizing rules unchanged since last check.
- [[03_AGENT_RUNS/09_ORCHESTRATOR/ORCHESTRATOR_2026-09-02_001]] — yesterday's Daily Anchor first-line verdict and baseline convictions for all 8 holdings; source of the 8-vs-7-cap and PLTR/NVDA concentration finding, and the WULF/IREN evidence-gate framing this run re-tests.
- [[03_AGENT_RUNS/06_PORTFOLIO_COURT/PORTFOLIO_COURT_2026-09-02_001]] — yesterday's Daily Anchor Portfolio Court run (100%-cash trial → NVDA, next-euro ranking → HOLD CASH, portfolio-count overage, PLTR+NVDA concentration). This week's re-validation confirms or updates against that baseline rather than re-deriving from scratch.
- [[03_AGENT_RUNS/05_UNDERWRITER/UNDERWRITER_2026-09-03_0740_WEEKLY]] — this week's thesis re-validation for all 9 tracked names (8 holdings + ONDS). Verdict `WEEKLY UNDERWRITING = COMPLETE`, **0 material thesis changes**, 0 kill conditions triggered or near-trigger, 3 genuine-but-non-material deltas assessed (PLTR downgrade, MSFT 8-K segment overhaul, TSLA Cybercab launch today).
- [[02_ACTIVE_HANDOFF/CAOS — ACTIVE HANDOFF SNAPSHOT]] — 3 open items carried from yesterday: `20260902-DAILY-ONDS-NEW_CHALLENGER` (Challenger, not a funded holding — out of this role's scope), `20260902-DAILY-PORTFOLIO-COUNT_OVERAGE` (system-state, routed to Deep Audit, `MANDATORY_DEEP_UNDERWRITING = YES`), `20260902-DAILY-WULF_IREN-EVIDENCE_GATE` (Anthropic credit-standing gap, `MANDATORY_DEEP_UNDERWRITING = YES`). None resolved by any input this week.
- `03_AGENT_RUNS/06_PORTFOLIO_COURT/_AGENT SPEC — Portfolio Court (Weekly Ranking).md` — this run's role spec.

**ACK check:** All three open handoffs read. None require action from this role — `PORTFOLIO-COUNT_OVERAGE` and `WULF_IREN-EVIDENCE_GATE` are both routed to Deep Audit (`NEXT_GATE = Deep Audit`), not to this weekly conviction re-check; `ONDS-NEW_CHALLENGER` is a Challenger, out of scope for Funded Holdings Only. This run neither resolves nor duplicates any of the three — it re-confirms they remain open and unchanged since yesterday.

**Scope note (per spec):** this is a mandatory weekly re-validation of thesis and weight for every funded CORE/ATTACKER holding, not a capital allocation tribunal. No sells, reallocations, or role reassignments are recommended here. Underwriter's Weekly found essentially nothing changed in the 24 hours since Daily Anchor — accordingly this run re-confirms yesterday's findings per holding, citing rather than re-deriving, and flags only what actually moved (none did, materially).

---

## 1. Funded Holdings List (all CORE/ATTACKER, per Master Ledger §2/§4)

PLTR, NVDA, MSFT, KO, GOOGL, TSLA, IREN, WULF — 8 securities, unchanged share counts from yesterday (confirmed against Ledger to 8 decimal places; no fills logged in §9 since 2026-09-02).

## 2. Current Weight Recomputation

Position value = shares × Ledger's 2026-09-02 current price (this week's Verifier could not establish a live 2026-09-03 price for any ticker — market closed pre-open, aggregator layer DATA LIMITED per Underwriter's Inputs Consulted — so the Ledger's 2026-09-02 snapshot is carried forward as the weekly denominator, consistent with Underwriter's own treatment this run). Weights are of the sum of the 8 holdings' value (~$10,818, USD-denominated; the Ledger's €9,333.67 total is mixed-currency and not independently reconciled here) — an approximation, not an exact %-of-NAV audit (Verifier/Deep Audit's job to compute precisely, same caveat as yesterday).

| Ticker | Shares | Price (2026-09-02, carried fwd) | Value (USD) | Weight |
|---|---|---|---|---|
| PLTR | 21.68808861 | $177.56 | $3,852.14 | 35.6% |
| NVDA | 14.88458404 | $216.89 | $3,228.30 | 29.8% |
| MSFT | 1.96105021 | $497.14 | $975.03 | 9.0% |
| KO | 11.07061496 | $88.11 | $975.35 | 9.0% |
| GOOGL | 1.85516511 | $336.75 | $624.83 | 5.8% |
| TSLA | 1.67642235 | $356.00 | $596.81 | 5.5% |
| IREN | 8.1098693 | $36.01 | $292.04 | 2.7% |
| WULF | 18.91535598 | $14.46 | $273.56 | 2.5% |

**Unchanged from yesterday's Daily Anchor check** (same prices, same shares) — PLTR ~35.6% and NVDA ~29.8% remain, together, ~65% of the funded book, both multiples over the draft ~5% Core/Attacker sizing norm (Master Ledger §11, DRAFT, unconfirmed). This is not a new finding; it is the same standing concentration issue flagged yesterday and routed to Deep Audit via `20260902-DAILY-PORTFOLIO-COUNT_OVERAGE` — restated here as required weight data, not re-escalated as new.

## 3. Survival Scores — Explicit, With Delta

Per Underwriter's Weekly (§Summary): **no numeric 0-100 survival-score baseline has ever been assigned to any of the 8 holdings** — yesterday's Monster Census used qualitative evidence/survivability-adjusted attractiveness labels only, and this week's Underwriter correctly declined to invent numbers to fill a table cell. This role inherits that same limitation rather than fabricating a score. Survival % is stated as `DATA LIMITED — no numeric baseline exists` for every holding; direction is stated qualitatively against last week's descriptive baseline.

| Ticker | Survival % | Delta from last check |
|---|---|---|
| PLTR | DATA LIMITED (no numeric baseline; no Monster File on file) | n/a — unchanged qualitative status (held on priors) |
| NVDA | DATA LIMITED (no numeric baseline) | Stable — qualitative baseline "highest evidence quality in the book" reconfirmed, no degradation |
| MSFT | DATA LIMITED (no numeric baseline) | Stable — evidentiary quality **improved** (FY27 segment-reporting overhaul makes Azure growth independently falsifiable going forward); fundamentals unchanged |
| KO | DATA LIMITED (no numeric baseline) | Stable — no new evidence; mandate-fit question (low-CAGR fit) unchanged from yesterday, still routed to Deep Audit |
| GOOGL | DATA LIMITED (no numeric baseline) | Stable — no fresh evidence either direction, held on priors |
| TSLA | DATA LIMITED (no numeric baseline) | Stable — Cybercab launch *event* tightened from UNVERIFIED LEAD to VERIFIED FACT (date/time confirmed); commercial-rollout-scale claim remains UNVERIFIED LEAD, unresolved at run time |
| IREN | DATA LIMITED (qualitative baseline: "MODERATE-TO-GOOD, evidence-backed but execution-dependent") | Stable — no new contract/financing/counterparty disclosure since 2026-09-02; 82% trailing-mining revenue and ~$8B unfinanced FY27 gap unchanged |
| WULF | DATA LIMITED (qualitative baseline: "MIXED — more open questions than IREN's") | Stable — no new contract/financing/counterparty disclosure since 2026-09-02; Anthropic credit-standing gap unchanged, evidence gate still open |

No holding shows a >10-point-equivalent (or qualitative-tier) degradation this week — consistent with Underwriter's finding of 0 material thesis changes.

## 4. Execution Risk Assessment (financing, dilution, liquidity, durability)

- **PLTR:** No fresh evidence this week (no Monster File baseline exists). One nonbinding, single-contributor "Distribute" rating (valuation-driven, stock trading above the analyst's own PT) — opinion noise, not an execution-risk finding. No dilution/financing/liquidity concern raised.
- **NVDA:** No new competitor-share, margin, or Vera Rubin-ramp evidence this week; all three of yesterday's kill conditions remain untriggered. Execution risk unchanged — supply-constrained, not demand- or financing-constrained.
- **MSFT:** No financing/dilution/liquidity concern (mega-cap, self-funding capex). Sole development is a disclosure-format change (8-K segment overhaul), which is a durability-of-evidence positive, not a new risk.
- **KO:** No financing/dilution/liquidity concern. Routine dividend continuity (64th consecutive annual increase) reaffirms capital-return durability. Sole open item is mandate-fit (low CAGR vs. maximize-CAGR objective), not execution risk — unchanged from yesterday, Deep Audit's to resolve.
- **GOOGL:** No new financing/dilution/liquidity evidence this week; FY26 capex raise ($195B–$205B) is the standing baseline, not newly revised.
- **TSLA:** No dilution/liquidity concern. The one live execution-risk item is the Cybercab launch itself — event confirmed happening today; whether commercial rider-hailing rollout matches the "as early as next week" claim is unresolved at this run's timestamp and is explicitly flagged (by Underwriter) as tomorrow's first required check, not something this run can adjudicate.
- **IREN:** Financing: Microsoft/Horizon facility remains investment-grade-rated and unchanged. Open item unchanged from yesterday: ~$8B FY27 capex gap remains unfinanced (management aspiration, not secured). Liquidity/durability: 82% of trailing FY26 revenue still bitcoin-mining. All 5 of yesterday's kill conditions untriggered.
- **WULF:** Financing/leverage unchanged: $5.8B total debt (~63% of a naive debt+equity cap), $2.5B convertible notes with refinancing/conversion risk ahead of H2 2027 revenue start. The Anthropic counterparty-credit gap (unrated, pre-IPO, no revenue until H2 2027) remains open and unresolved by any input this week — this is the same standing gap from `20260902-DAILY-WULF_IREN-EVIDENCE_GATE`, not a new deterioration. All 6 of yesterday's kill conditions untriggered; nearest-to-watch remains condition (1), Anthropic's IPO/financing process.

**Cross-cutting note carried from yesterday's Orchestrator, still live:** the "WULF is the weaker holding" framing was found to be directionally correct but magnitude-overstated by Red Team — WULF's trailing revenue mix is actually further along its AI/HPC pivot (71% HPC-derived, VERIFIED FACT) than IREN's (82% still bitcoin-mining). This run does not re-litigate that finding; it notes both names get equal-weight scrutiny below, not WULF-under-a-microscope treatment.

---

## Holdings Re-Validation Table

| Ticker | Position | Current Weight | Thesis Verdict | Survival % | Conviction | Action | Escalate? |
|---|---|---|---|---|---|---|---|
| PLTR | CORE/ATTACKER | 35.6% | CONFIRMED (no fresh evidence to move it; nonbinding single-analyst downgrade assessed, non-material) | DATA LIMITED — no numeric baseline | MEDIUM, stable (held on priors — no Monster Census thesis file exists) | HOLD | No |
| NVDA | CORE/ATTACKER | 29.8% | INTACT | DATA LIMITED — no numeric baseline | HIGH, stable | HOLD | No |
| MSFT | CORE/ATTACKER | 9.0% | INTACT (evidence quality strengthened; fundamentals unchanged) | DATA LIMITED — no numeric baseline | HIGH, stable | HOLD | No |
| KO | CORE/ATTACKER | 9.0% | INTACT | DATA LIMITED — no numeric baseline | MEDIUM, stable (mandate-fit question open, Deep Audit's to resolve) | HOLD | No |
| GOOGL | CORE/ATTACKER | 5.8% | CONFIRMED (no fresh evidence, held on priors) | DATA LIMITED — no numeric baseline | MEDIUM-HIGH, stable | HOLD | No |
| TSLA | CORE/ATTACKER | 5.5% | INTACT (catalyst-in-progress, unresolved at run time) | DATA LIMITED — no numeric baseline | MEDIUM, stable | HOLD | No |
| IREN | CORE/ATTACKER | 2.7% | INTACT | DATA LIMITED — qualitative baseline "MODERATE-TO-GOOD," unchanged | MEDIUM, stable | HOLD | No |
| WULF | CORE/ATTACKER | 2.5% | INTACT | DATA LIMITED — qualitative baseline "MIXED," unchanged | MEDIUM, stable | HOLD | No |

---

## 5. What Did Not Change (explicit, per spec's cite-not-rederive expectation)

- 0 material thesis changes across all 8 holdings (Underwriter Weekly).
- 0 kill conditions triggered or near-trigger, across the 4 tickers with defined kill conditions (NVDA, IREN, WULF, ONDS — ONDS not a funded holding).
- 0 survival-score deltas (no numeric baseline to move; qualitative baselines all reconfirmed unchanged).
- Portfolio weights unchanged (same prices, same shares as yesterday's check — no live 2026-09-03 price available).
- Both open evidence gates (`PORTFOLIO-COUNT_OVERAGE`, `WULF_IREN-EVIDENCE_GATE`) remain open, unresolved by any input this week, and remain routed to Deep Audit — this role does not and cannot resolve them (out of scope: role reassignment and rule confirmation are Deep Audit's/Mark's, not Portfolio Court's).

## 6. Escalation Check

Per spec, escalation triggers on: thesis killed (core assumption false), survival <30%, key catalyst date missed, or execution risk suddenly elevated. None of these occurred this week for any of the 8 holdings — 0 material changes, 0 kill-condition triggers, no catalyst miss (TSLA's Cybercab catalyst is *today*, not missed), no sudden execution-risk elevation. **No new escalation is issued by this run.** The two open Deep-Audit-bound items (portfolio count/concentration; WULF/IREN evidence gate) are pre-existing handoffs from yesterday, not new escalations from this weekly check — they are correctly not duplicated here per Active Handoff's rule against re-emitting unresolved items.

---

## Verdict

```
PORTFOLIO COURT (WEEKLY) = ALL FUNDED HOLDINGS VALIDATED
```

**Reasoning:** All 8 CORE/ATTACKER funded holdings were re-validated against Underwriter's Weekly thesis re-check (0 material changes, 0 kill-condition triggers), current Ledger weights (unchanged, live price unavailable this run), and execution-risk factors (financing, dilution, liquidity, durability — no deterioration on any name). No holding's thesis moved to DEGRADED or SHIFT RECOMMENDED; no survival score fell below a concerning threshold (none exist numerically, and no qualitative baseline degraded); no catalyst was missed. The two structural items carried from yesterday — 8-vs-7 portfolio-count overage and PLTR+NVDA concentration (~65% combined) — remain open, unresolved, and correctly routed to Deep Audit rather than acted on here; this weekly re-check does not treat an unresolved structural handoff as a holdings-validation failure, consistent with this role's scope (thesis/conviction re-check only, never sizing or role reassignment).
